ID24870A - Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi - Google Patents

Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi

Info

Publication number
ID24870A
ID24870A IDW20000183A ID20000183A ID24870A ID 24870 A ID24870 A ID 24870A ID W20000183 A IDW20000183 A ID W20000183A ID 20000183 A ID20000183 A ID 20000183A ID 24870 A ID24870 A ID 24870A
Authority
ID
Indonesia
Prior art keywords
salt
physiology
complexes
accepted
vanadium compounds
Prior art date
Application number
IDW20000183A
Other languages
English (en)
Indonesian (id)
Inventor
Conradus Ghosal Gho
Original Assignee
Gho St Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gho St Holding Bv filed Critical Gho St Holding Bv
Publication of ID24870A publication Critical patent/ID24870A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IDW20000183A 1997-07-29 1998-07-29 Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi ID24870A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1006681A NL1006681C2 (nl) 1997-07-29 1997-07-29 Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.

Publications (1)

Publication Number Publication Date
ID24870A true ID24870A (id) 2000-08-31

Family

ID=19765422

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000183A ID24870A (id) 1997-07-29 1998-07-29 Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi

Country Status (22)

Country Link
US (2) US6579540B1 (xx)
EP (1) EP1001792B1 (xx)
JP (1) JP2001511454A (xx)
CN (1) CN1104244C (xx)
AT (1) ATE253373T1 (xx)
AU (1) AU738701B2 (xx)
BR (1) BR9811298A (xx)
CA (1) CA2298645C (xx)
CZ (1) CZ299716B6 (xx)
DE (1) DE69819514T2 (xx)
DK (1) DK1001792T3 (xx)
EA (1) EA002574B1 (xx)
ES (1) ES2207851T3 (xx)
ID (1) ID24870A (xx)
IL (2) IL134259A0 (xx)
NL (1) NL1006681C2 (xx)
NO (1) NO20000446L (xx)
NZ (1) NZ502613A (xx)
PL (1) PL338415A1 (xx)
PT (1) PT1001792E (xx)
TR (1) TR200000349T2 (xx)
WO (1) WO1999006056A1 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.
US8192994B2 (en) * 1998-02-10 2012-06-05 Angros Lee H Method of applying a biological specimen to an analytic plate
AU1898700A (en) * 1999-12-20 2001-07-03 Gho'st Holding B.V. Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and NA+/H+ exchange inhibitor
WO2003041703A2 (en) * 2001-11-16 2003-05-22 Gho Holding B.V. Use of a flavonoid for the treatment of burns
CA2673413A1 (en) 2007-01-31 2008-08-07 Basf Plant Science Gmbh Plants having enhanced yield-related traits and/or increased abiotic stress resistance, and a method for making the same
ES2403281T3 (es) 2007-05-03 2013-05-17 Basf Plant Science Gmbh Plantas que tienen rasgos relacionados con producción mejorada y un método para elaborarlas
ES2440265T3 (es) 2007-07-20 2014-01-28 Basf Plant Science Gmbh Plantas que tienen un aumento de características relacionadas con el rendimiento y un método para elaboración de las mismas
AR067748A1 (es) 2007-07-31 2009-10-21 Basf Plant Science Gmbh Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas
US20110179526A1 (en) 2007-10-29 2011-07-21 Basf Plant Science Gmbh Plants having enhanced yield-related traits and a method for making the same
EP2274431A1 (en) 2008-05-05 2011-01-19 BASF Plant Science GmbH Plants having enhanced yield-related traits and a method for making the same
US20100078320A1 (en) * 2008-09-26 2010-04-01 Applied Materials, Inc. Microwave plasma containment shield shaping
JP5878477B2 (ja) 2010-01-15 2016-03-08 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 骨の治癒を加速するためのバナジウム化合物の使用
WO2012079024A2 (en) 2010-12-10 2012-06-14 University Of Medicine And Dentistry Of New Jersey Implantable devices coated with insulin-mimetic agent composites and methods thereof
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
HUE046642T2 (hu) * 2011-03-07 2020-03-30 Cfm Pharma Holding Bv Vanádium vegyületek alkalmazása normaglikémia fenntartására emlõsben
US9931348B2 (en) * 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair
PL231079B1 (pl) 2012-11-07 2019-01-31 Univ Jagiellonski Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami
NL2019605B1 (en) * 2017-09-22 2019-03-28 Cfm Pharma Holding B V Vanadyl and vanadate for use in reducing stress-induced metabolic derangement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5448490A (en) * 1989-04-24 1990-11-16 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
US5565491A (en) * 1994-01-31 1996-10-15 Bristol-Myers Squibb Company Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
NL1006681C2 (nl) * 1997-07-29 1999-02-08 Gho St Holding Bv Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen.

Also Published As

Publication number Publication date
CN1104244C (zh) 2003-04-02
ES2207851T3 (es) 2004-06-01
EP1001792B1 (en) 2003-11-05
CA2298645C (en) 2004-05-18
NL1006681C2 (nl) 1999-02-08
CZ299716B6 (cs) 2008-10-29
PL338415A1 (en) 2000-11-06
NZ502613A (en) 2001-08-31
BR9811298A (pt) 2000-08-29
IL134259A (en) 2010-02-17
WO1999006056A1 (en) 1999-02-11
NO20000446L (no) 2000-03-24
JP2001511454A (ja) 2001-08-14
CZ2000326A3 (cs) 2000-07-12
US6579540B1 (en) 2003-06-17
DE69819514D1 (de) 2003-12-11
NO20000446D0 (no) 2000-01-28
TR200000349T2 (tr) 2000-09-21
CA2298645A1 (en) 1999-02-11
EA200000176A1 (ru) 2000-10-30
AU8650598A (en) 1999-02-22
EP1001792A1 (en) 2000-05-24
IL134259A0 (en) 2001-04-30
EA002574B1 (ru) 2002-06-27
ATE253373T1 (de) 2003-11-15
DE69819514T2 (de) 2004-09-23
CN1270525A (zh) 2000-10-18
US20030211170A1 (en) 2003-11-13
PT1001792E (pt) 2004-03-31
AU738701B2 (en) 2001-09-27
DK1001792T3 (da) 2004-01-19

Similar Documents

Publication Publication Date Title
ID24870A (id) Penggunaan senyawa vanadium, garam dan kompleksnya yang dapat diterima secara fisiologi
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
HUP0102521A2 (hu) Sztilbénszármazékot és platina koordinációs vegyületet tartalmazó daganatellenes szer
SE9701162D0 (sv) New use II
WO2003009838A1 (fr) Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
BR0010531A (pt) Composições e usos de et743 para tratamento de câncer
WO1998009599A3 (fr) Utilisation d'un nouvel acide bicafeoylquinique dans le traitement de l'hepatite b et des maladies liees a des retrovirus, et derives de cet acide bicafeolyquinique
HK1037980A1 (en) Use of selegiline or desmethylselegiline for the manufacture of a medicament for treating wounds, burns or photodamage.
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
CA2385755A1 (en) Prevention of colorectal cancer
EP0338415A3 (en) Use of sulphonylureas in the treatment of oedema
GEP20043231B (en) Resorcinol Composition
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
WO2001045717A3 (en) Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
GR20010100390A (el) Χρηση του diclofenac h αποδεκτων αλατων αυτου για την αντιμετωπιση των εγκαυματων.
MY143194A (en) Topical pharmaceutical compositions for healing wounds
IL129267A (en) Pharmaceutical compositions comprising histamine and/or serotonin for treatment of urinary incontinence
ATE464051T1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
CZ176395A3 (en) The use of riluzol for preparing medicaments acceptable as antidotes against harmful effects of irradiation